Upon launching our lawsuit we immediately began to receive questions about whether our goal is to address certain diseases (while therefore excluding others). The short and simple answer is “No.” Our goal is to increase the number of people that follow through with marrow donation, especially among those with rare marrow type, regardless of disease. See this article from the Myeloma Beacon about how our pilot program could address multiple myeloma patients.
Tags: myeloma, Shaka Mitchell, transplant